Baxter has introduced the Hemopatch Sealing Hemostat with room temperature storage, enhancing surgical accessibility across Europe.
The Hemopatch new Sealing Hemostat is an absorbable collagen pad designed for tissue and dura sealing, as well as haemostasis.
It allows surgeons to quickly address bleeding or leakage during procedures, and is suitable for both open and minimally invasive surgeries
Real-world data from Europe indicates its effectiveness in achieving rapid and sustainable hemostasis across various surgical specialties.
Baxter advanced surgery president Steve Wallace said: “For over a decade, Hemopatch Sealing Hemostat has offered surgeons a reliable solution for tissue sealing, dura sealing, and haemostasis.
“The product evolution to include room temperature storage is a result of close collaboration between surgeons and Baxter.
“Removing the need for refrigeration addresses the needs of our customers to have the product on hand in critical situations. We are proud to continue Baxter’s legacy of innovation in sealing and haemostasis.”
The product features a soft, thin, and flexible collagen pad derived from bovine dermis, coated with NHS-PEG. Its design allows for controlled application to desired sites.
The non-coated side is distinguished by blue squares made with a biocompatible colourant, aiding in precise placement during surgery.
Baxter is a healthcare company focused on saving lives through various medical products and therapies, with a focus on saving and sustaining lives.
The company’s portfolio includes diagnostic, critical care, nutrition, hospital, and surgical products, serving patient homes, hospitals, and physician offices.
In August last year, Baxter signed a definitive agreement to divest its Kidney Care unit, which will be named as Vantive, to investment firm Carlyle for $3.8bn.
In October, the company announced a two-year extension of its partnership with Oneview Healthcare, a provider of patient experience solutions, to include Canada.
Both firms initially signed a value-added reseller agreement in June 2023 for the US market.
The expanded partnership allows Baxter to sell, quote, contract, and deliver Oneview solutions through comprehensive training in Baxter’s Care & Connectivity Solutions division.
